AR073934A1 - Terpenos macrociclos, proceso para su preparacion, medicamentos que los contienen y uso de los mismos - Google Patents

Terpenos macrociclos, proceso para su preparacion, medicamentos que los contienen y uso de los mismos

Info

Publication number
AR073934A1
AR073934A1 ARP090102022A ARP090102022A AR073934A1 AR 073934 A1 AR073934 A1 AR 073934A1 AR P090102022 A ARP090102022 A AR P090102022A AR P090102022 A ARP090102022 A AR P090102022A AR 073934 A1 AR073934 A1 AR 073934A1
Authority
AR
Argentina
Prior art keywords
denotes
nhc
mcoor4
hal
alkyl
Prior art date
Application number
ARP090102022A
Other languages
English (en)
Inventor
Delphine Jacquot
Oliver Poeschke
Christa Burger
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR073934A1 publication Critical patent/AR073934A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/58—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/737—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30—Unsaturated compounds
    • C07C62/38—Unsaturated compounds containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
    • C07C2603/78—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing seven-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Nuevos terpenos y macrociclos son activadores de TGR5 y se pueden usar para la prevencion y/o el tratamiento de diabetes de tipo 2, obesidad, neuropatía y/o nefropatía. Reivindicacion 1: Compuestos seleccionados del grupo a) compuestos de la formula (1) en la que R1 denota OH, OA, OAr, OC(O)A, OC(O)Ar, NH2, NHA, NA2, NHAr, NHC(O)A o NHC(O)Ar, R2 denota O, OH, OA, OAr, OC(O)A, OC(O)Ar, NH2, NHA, NA2, NHAr, NHC(O)A o NHC(O)Ar, R3 denota H, A o Ar; X denota CH2 o CO, R4 denota H o alquilo C1-4, ----- denota un enlace simple o un enlace doble, A denota alquilo no ramificado o ramificado C1-10, en donde 1-7 átomos de H pueden estar reemplazados por F y/o Cl, Ar denota fenilo, naftilo o bifenilo, cada uno de los cuales no está sustituido o esta mono-, di- o trisustituido con Hal, A, OR4, N(R4)2, NO2, CN, COOR4, CON(R4)2, NR4COA, NR4SO2A, COR4, SO2N(R4)2, S(O)nA, [C(R4)2]mCOOR4 y/u O[C(R4)2]mCOOR4, m denota 0, 1, 2, 3 o 4, n denota 0, 1 o 2; Hal denota F, Cl, Br o I; b) compuestos de la formula (2) en la que R1 denota OH, OA, OAr, NH2, NHA, NA2, NHAr, NH(CH2)pNH2, NH(CH2)pNHA, NH(CH2)pNA2, R2 denota H, A o Ar; R4 denota H o alquilo C1-4, ----- denota un enlace simple o un enlace doble, A denota alquilo no ramificado o ramificado C1-10, en donde 1-7 átomos de H pueden estar reemplazados por F y/o Cl, Ar denota fenilo, naftilo o bifenilo, cada uno de los cuales no está sustituido o está mono-, di- o trisustituido con Hal, A, OR4, N(R4)2, NO2, CN, COOR4, CON(R4)2, NR4COA, NR4SO2A, COR4, SO2N(R4)2, S(O)nA, [C(R4)2]mCOOR4 y/u O[C(R4)2]mCOOR4, m denota 0, 1, 2, 3 o 4, n denota 0, 1 o 2; p denota 1, 2, 3 o 4, Hal denota F, Cl, Br o I; c) compuestos de la formula (3) en la que R1 denota O, OH, OA, OAr, OC(O)A, OC(O)Ar, NH2, NHA, NA2, NHAr, NHC(O)A o NHC(O)Ar, R2 denota O, OH, OA, OAr, OC(O)A, OC(O)Ar, NH2, NHA, NA2, NHAr, NHC(O)A o NHC(O)Ar, R3 denota H, A o Ar; R4 denota H o alquilo C1-4, ----- denota un enlace simple o un enlace doble, A denota alquilo no ramificado o ramificado C1-10, en donde 1-7 átomos de H pueden estar reemplazados por F y/o Cl, Ar denota fenilo, naftilo o bifenilo, cada uno de los cuales no está sustituido o esta mono-, di- o trisustituido con Hal, A, OR4, N(R4)2, NO2, CN, COOR4, CON(R4)2, NR4COA, NR4SO2A, COR4, SO2N(R4)2, S(O)nA, [C(R4)2]mCOOR4 y/u O[C(R4)2]mCOOR4, m denota 0, 1, 2, 3 o 4, n denota 0, 1 o 2; Hal denota F, Cl, Br o I; d) compuestos de la formula (4) en la que R1 denota OH, OA, OAr, OC(O)A, OC(O)Ar, NH2, NHA, NA2, NHAr, NHC(O)A o NHC(O)Ar, R4 denota H o alquilo C1-4, ----- denota un enlace simple o un enlace doble, A denota alquilo no ramificado o ramificado C1-10, en donde 1-7 átomos de H pueden estar reemplazados por F y/o Cl, Ar denota fenilo, naftilo o bifenilo, cada uno de los cuales no está sustituido o está mono-, di- o trisustituido con Hal, A, OR4, N(R4)2, NO2, CN, COOR4, CON(R4)2, NR4COA, NR4SO2A, COR4, SO2N(R4)2, S(O)nA, [C(R4)2]mCOOR4 y/u O[C(R4)2]mCOOR4, m denota 0, 1, 2, 3 o 4, n denota 0, 1 o 2; Hal denota F, Cl, Br o I; y sus sales y estereoisomeros farmacéuticamente aceptables, incluyendo sus mezclas en todas las proporciones. Reivindicacion 4: Proceso para la preparacion de compuestos da la formula 1, 2 y 4 y sus sales y estereoisomeros farmacéuticamente aceptables, caracterizado porque un radical R1 se convierte en otro radical R1 al convertir un grupo hidroxilo o alcoxi en un grupo amino opcionalmente sustituido y/o una base o un ácido de la formula 1, 2 o 4 se convierte en una de sus sales. Reivindicacion 6: Medicamentos que comprenden al menos un compuesto de acuerdo con la reivindicacion 1-3 y/o sus sales y estereoisomeros farmacéuticamente aceptables, incluyendo sus mezclas en todas las proporciones, y opcionalmente excipientes y/o adyuvantes. Reivindicacion 7: Uso de compuestos de acuerdo con la reivindicacion 1-3, y sus sales y estereoisomeros farmacéuticamente aceptables, incluyendo sus mezclas en todas las proporciones, para preparar un medicamento para el tratamiento de una enfermedad o condicion patologica, donde la enfermedad o condicion patologica es diabetes mellitus insulinodependiente, diabetes mellitus no insulinodependiente, obesidad, neuropatía y/o nefropatía.
ARP090102022A 2008-06-07 2009-06-05 Terpenos macrociclos, proceso para su preparacion, medicamentos que los contienen y uso de los mismos AR073934A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08010413 2008-06-07

Publications (1)

Publication Number Publication Date
AR073934A1 true AR073934A1 (es) 2010-12-15

Family

ID=40765779

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090102022A AR073934A1 (es) 2008-06-07 2009-06-05 Terpenos macrociclos, proceso para su preparacion, medicamentos que los contienen y uso de los mismos

Country Status (13)

Country Link
US (1) US20110092582A1 (es)
EP (1) EP2285788A1 (es)
JP (1) JP2011522807A (es)
KR (1) KR20110031184A (es)
CN (1) CN102056908A (es)
AR (1) AR073934A1 (es)
AU (1) AU2009254303A1 (es)
BR (1) BRPI0913125A2 (es)
CA (1) CA2726883A1 (es)
IL (1) IL209420A0 (es)
MX (1) MX2010013301A (es)
WO (1) WO2009146772A1 (es)
ZA (1) ZA201100182B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10703761B2 (en) * 2016-10-18 2020-07-07 City Of Hope Bile acid receptor modulators and methods of use thereof
CN115569130B (zh) * 2022-10-09 2024-02-09 东莞广州中医药大学研究院 环氧广藿香烯及其组合物在制备预防和/或治疗非酒精性脂肪肝药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2908310B1 (fr) * 2006-11-14 2009-07-10 Phytodia Produits agonistes de tgr5 et leurs applications

Also Published As

Publication number Publication date
CN102056908A (zh) 2011-05-11
ZA201100182B (en) 2011-10-26
AU2009254303A1 (en) 2009-12-10
BRPI0913125A2 (pt) 2016-01-05
MX2010013301A (es) 2010-12-21
CA2726883A1 (en) 2009-12-10
WO2009146772A1 (en) 2009-12-10
EP2285788A1 (en) 2011-02-23
US20110092582A1 (en) 2011-04-21
JP2011522807A (ja) 2011-08-04
KR20110031184A (ko) 2011-03-24
IL209420A0 (en) 2011-01-31

Similar Documents

Publication Publication Date Title
TN2010000026A1 (fr) Nouveaux derives de 6-triazolopyridazine-sulfanyl benzothiazole et benzimidazole, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met
AR081337A1 (es) Derivados de 1,4-benzotiazepinas, composiciones farmaceuticas que los comprenden y su uso en la preparacion de un medicamento para el tratamiento de trastornos metabolicos
PE20070519A1 (es) Derivados de fenilmorfolina y feniltiomorfolina como agonistas de adrenoreceptores alfa 2c
AR077464A1 (es) Terapia de combinacion para el tratamiento de la diabetes
AR052256A1 (es) Derivados de tetrahidropirano y su uso como agentes antidiabeticos
AR056986A1 (es) Aza heterociclos como inhibidores de quinasas. procedimiento de obtencion y composiciones farmaceuticas
AR073138A1 (es) Derivados de dioxa-biciclo (3.2.1) octano- 2,3,4-triol
AR055060A1 (es) Derivados de n-(piridin-2-il)-sulfonamida
AR081058A1 (es) Derivados de arilmetoxi isoindolina, composiciones que los comprenden y su uso en el tratamiento del cancer.
AR062357A1 (es) Derivados de fenilo, piridina y quinolina, composiciones farmaceuticas y su utilizacion como medicamentos
EA201500266A1 (ru) Ингибиторы репликации вирусов гриппа
UY29393A1 (es) Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones.
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
AR067538A1 (es) Inhibidortes de la 11 beta -hidroxiesteroide-deshidrogenasa
AR079448A1 (es) Inhibidores de la esfingosina quinasa
AR077413A1 (es) Derivados piridin-4-ilo
AR070458A1 (es) Derivados de oxazolidina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de una infeccion bacteriana.
AR058398A1 (es) Diazepinonas, procesos de obtencion , composiciones farmaceuticas y su uso como inhibidores de quinasas.
AR070820A1 (es) Derivados de piridina agonistas del receptor s1p1/edg1, procesos de preparacion, composiciones y usos
AR084011A1 (es) Compuestos nitrogenados heterociclicos utiles para el tratamiento de infecciones por el virus sincitial respiratorio (rsv), proceso para prepararlos y composiciones farmaceuticas que los contienen
AR079260A1 (es) Inhibidores de bencimidazol de la produccion de leucotrienos, un procedimiento para su preparacion, composiciones farmaceuticas que los comprenden y su empleo como medicamentos en el tratamiento de trastornos mediados por leucotrienos
BR0214675A (pt) Novos compostos e seu uso em medicina, processo para seu preparo e composições farmacêuticas contendo os mesmos
AR073845A1 (es) Derivados de acido l-glutamico y l-glutamina marcados con [f-18] (i), su uso y procedimiento para su preparacion y composiciones farmaceuticas
AR059886A1 (es) Derivados de amidas como inhibidores de renina
UY29818A1 (es) Nuevos compuestos de azetidina, composiciones farmaceuticas que los contienen, procesos de preparacion y sus usos terapeuticos

Legal Events

Date Code Title Description
FB Suspension of granting procedure